Skip to content

Pulse Biosciences, Inc. PLSE Other Receivable From Exercise Of Warrants And Stock Options

Other Receivable From Exercise Of Warrants And Stock Options at other companies

Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$3K-80.0%
Tyra Biosciences, Inc. logo
Tyra Biosciences, Inc.TYRA
$60.25K
Lightwave Logic, Inc. logo
Lightwave Logic, Inc.LWLG
$1.86M+1,039%
C3.ai logo
C3.aiAI
$0-100%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$2.97M
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$304K

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept plse:OtherReceivableFromExerciseOfWarrantsAndStockOptions.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s other receivable from exercise of warrants and stock options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s other receivable from exercise of warrants and stock options?
Pulse Biosciences, Inc. (PLSE) reported other receivable from exercise of warrants and stock options of $88K in Q1 2026.
What does other receivable from exercise of warrants and stock options mean?
This metric tracks the amount of cash due to the company resulting from the exercise of warrants or stock options that has not yet been collected at the reporting date. It represents a short-term financial asset that reflects the timing difference between the exercise event and the final settlement of funds.